RSV Alert: Key Information for This Season’s Respiratory Virus Spread

MEXICO CITY (apro).— The respiratory syncytial virus (RSV) is a pathogen that affects the respiratory tract and circulates annually during peak seasons for respiratory infections. The World Health Organization (WHO) reports that RSV is among the most common causes of respiratory infections in children under five years of age and in older adults. According to the WHO, most people are exposed to the virus within the first few years of life.

The WHO data shows that the virus causes millions of infection episodes worldwide, with a significant number of these leading to hospitalizations, mainly among infants and people over 60 years of age. The Centers for Disease Control and Prevention (CDC) in the United States point out that RSV is a major cause of pediatric hospitalizations there and remains a high-priority virus for surveillance during the winter season.

Analysis, context, and facts. Click and follow us on Google News

RSV belongs to the Pneumoviridae family and spreads through similar transmission routes as other respiratory viruses. The WHO explains that it spreads through close contact with infected individuals, via respiratory droplets from coughs or sneezes, and by touching contaminated surfaces. The virus’s ability to survive on surfaces can facilitate transmission in environments like daycare centers, schools, and homes where close interaction among children occurs.

Transmission and Identified High-Risk Groups According to Health Organizations

RSV circulates seasonally. In regions of the northern hemisphere, the CDC notes an increase in cases during autumn and winter, while in tropical climate countries, circulation may increase during the rainy season. The WHO states that these variations are dependent on climatic factors, population density, and social mobility.

The groups at higher risk of developing severe respiratory illness include infants under 12 months, premature babies, children with lung or heart diseases, older adults, and individuals with weakened immune systems. Mexico’s Ministry of Health recognizes RSV as one of the most significant respiratory agents for national epidemiological surveillance, especially among the pediatric population.

MedlinePlus, an information service of the U.S. National Institutes of Health, indicates that reinfection with RSV is common throughout life, as the immunity it generates is not permanent. Research highlighted by the Mayo Clinic agrees that adults may experience mild infections resembling common colds, whereas in infants, the infection can return with greater severity.

Clinical Signs and Diagnostic Methods

Health organizations describe early symptoms like nasal congestion, low-grade fever, dry cough, sneezing, and decreased appetite. In younger individuals, the virus can progress to bronchiolitis or pneumonia, according to Mayo Clinic reports. The CDC emphasizes that difficulty breathing, wheezing, or rapid breathing are warning signs that require immediate medical evaluation.

The diagnosis of RSV is made through rapid antigen detection tests or molecular tests that identify the virus’s genetic material. The CDC advises that these diagnostic tests be used more frequently in infants, older adults, and patients with chronic diseases, due to the potential for respiratory complications that may require oxygenation or hospitalization.

Prevention and Immunization Tools

The WHO and CDC recommend preventive measures to reduce the virus’s spread. These include frequent hand washing with soap and water, ventilating enclosed spaces, covering the mouth and nose when coughing or sneezing, and avoiding contact with sick individuals. Mexico’s Ministry of Health includes similar guidelines in its epidemiological advisories directed at medical units and the general public.

In recent years, the WHO has acknowledged the use of immunization tools against RSV, such as monoclonal antibodies for infants and immunization products for older adults. These strategies aim to reduce the likelihood of severe disease and are part of prevention programs in various countries. The CDC explains that the availability of immunization options may vary based on supply and guidelines each season.

RSV Surveillance in the Americas and Mexico

The Pan American Health Organization (PAHO) includes RSV in its respiratory virus surveillance system, alongside influenza and SARS-CoV-2. This system provides regional reports that help countries adjust strategies for peak circulation seasons. The WHO notes that RSV surveillance helps anticipate increases in respiratory consultations and pediatric hospitalizations.

In Mexico, the Ministry of Health publishes epidemiological advisories related to RSV. These advisories include recommendations for timely diagnosis and case management in the country’s medical units. Mexican authorities note that RSV represents a significant burden among the population under five years old, especially between October and March.